Post-approval studies (Phase 4)Study completedNCT05398926
What this trial is testing
Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly
Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 400